Drug profile comparison
Showing 9976 - 10000 of >10,000
Onco-haematology Vigilance Card
Recruiting
- Medical Oncology
- +2 more
-
Limoges, FranceCHU de Limoges
Nov 2, 2021
Chronic Pouchitis, Pouchitis Trial in New York (Fecal Microbiota Transplant (FMT))
Not yet recruiting
- Chronic Pouchitis
- Pouchitis
- Fecal Microbiota Transplant (FMT)
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Apr 12, 2023
Cataract Trial in Vineland (Dexamethasone, Prednisolone Acetate 1% Oph Susp)
Recruiting
- Cataract
- Dexamethasone
- Prednisolone Acetate 1% Oph Susp
-
Vineland, New JerseyEye Associates of Vineland
Mar 17, 2021
Nebulizers and Vaporizers Trial in Uppsala (PreciseInhale, Seretide Evohaler forte)
Completed
- Nebulizers and Vaporizers
- PreciseInhale
- Seretide Evohaler forte
-
Uppsala, SwedenClinical Trial Consultants AB
Apr 1, 2022
Intubation Complication Trial in Kaohsiung (Henan Tuoren Endotracheal Tube, Smiths Portex Tracheal Tubes)
Recruiting
- Intubation Complication
- Henan Tuoren Endotracheal Tube
- Smiths Portex Tracheal Tubes
-
Kaohsiung, Sanmin District, TaiwanKaohsiung Medical University Chung-Ho Memorial Hospital
Oct 28, 2021
Primary Axillary Hyperhidrosis Trial in Rogers (Sofpironium Bromide Gel, 15%)
Completed
- Primary Axillary Hyperhidrosis
- Sofpironium Bromide Gel, 15%
-
Rogers, ArkansasNorthwest Arkansas Clinical Trials Center
Dec 19, 2022
Coronary Artery Disease Trial in Seoul
Recruiting
- Coronary Artery Disease
-
Seoul, Korea, Republic ofAsan Medical Center
Feb 14, 2022
Severe Aplastic Anemia (SAA) Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Eltrombopag)
Active, not recruiting
- Severe Aplastic Anemia (SAA)
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
May 12, 2021
Intravenous Drug Usage Trial in Chapel Hill (Behavioral Activation)
Completed
- Intravenous Drug Usage
- Behavioral Activation
-
Chapel Hill, North CarolinaUniversity of North Carolina at Chapel Hill
Aug 17, 2022
Atherosclerotic Cardiovascular Disease in Brazilian Population
Recruiting
- Cardiovascular Diseases
- +4 more
- Exposure to genetics (polygenic)
-
Rio Branco, AC, Brazil
- +40 more
Aug 23, 2022
Spine Surgery Trial in Louvain-la-Neuve (CADISS)
Completed
- Spine Surgery
- CADISS
-
Louvain-la-Neuve, BelgiumAuXin Surgery
Aug 16, 2021
Hemorrhage, Bleeding Trial (Tranexamic Acid Injection [Cyklokapron], Sodium chloride 0.9%)
Not yet recruiting
- Hemorrhage
- Bleeding
- Tranexamic Acid Injection [Cyklokapron]
- Sodium chloride 0.9%
- (no location specified)
Jul 15, 2022
Urinary Biomarkers in Paediatric Kidney Transplantation (pKTx)
Recruiting
- Renal Transplantation
- +2 more
- Biomarker test
-
Tuebingen, GermanyUniversity Children's Hospital Tuebingen
Jan 11, 2022
Epilepsy, Idiopathic Generalized Epilepsy, Generalized Tonic Clonic Seizure Trial (Responsive stimulation, Sham stimulation)
Not yet recruiting
- Epilepsy
- +2 more
- Responsive stimulation
- Sham stimulation
- (no location specified)
May 12, 2022
Ehlers-Danlos Syndrome (EDS) and Healthy Volunteers
Enrolling by invitation
- Ehlers-Danlos Syndrome
- Anesthesia, Local
- 0.9% Sodium Chloride Injection
- +2 more
-
Nashville, TennesseeVanderbilt University Medical Center
Sep 12, 2022
Diabetes, Type 1 Trial in Talcahuano (HIGH INTENSITY INTERVAL TRAINING)
Active, not recruiting
- Diabetes Mellitus, Type 1
- HIGH INTENSITY INTERVAL TRAINING
-
Talcahuano, Concepcion, ChileHospital Las Higueras
Aug 29, 2022
Drug-drug Interaction Trial in Guangzhou (ZSP1273, Oseltamivir)
Completed
- Drug-drug Interaction
-
Guangzhou, Guangdong, ChinaGuangdong Provincial Hospital of Chinese Medicine
Oct 24, 2021
Percutaneous Coronary Intervention Optimization With Fractional
Completed
- Coronary Artery Disease
- +2 more
- IVUS guided PCI optimization
- +2 more
- (no location specified)
Feb 19, 2023
Crohn's Disease, Inflammatory Bowel Disease Trial in Nashville (Ranolazine, Placebo)
Enrolling by invitation
- Crohn's Disease
- Inflammatory Bowel Disease
- Ranolazine
- Placebo
-
Nashville, TennesseeVanderbilt University Medical Center
May 20, 2022
Hairy Cell Leukemia Trial in La Jolla (Low dose vemurafenib plus rituximab)
Recruiting
- Hairy Cell Leukemia
- Low dose vemurafenib plus rituximab
-
La Jolla, CaliforniaScripps MD Anderson Cancer Center
May 19, 2022
Coronary Artery Disease, Coronary Occlusion, Percutaneous Coronary Intervention Trial in Beijing (drug, device, other)
Enrolling by invitation
- Coronary Artery Disease
- +4 more
- aspirin, betaloc, atorvastatin, rosuvastatin, clopidogrel, ticagrelor
- +3 more
-
Beijing, Beijing, ChinaDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medic
Feb 6, 2021
Apexification and Regenerative Endodontic Therapy:Retrospective
Completed
- Regenerative Endodontic
- +2 more
- Regenerative endodontics
-
Istanbul, TurkeyIstanbul University, Faculty of Dentistry
Jan 28, 2022